Previous Next


№3' 2019


International Medical Journal, Vol. 25., Iss. 3, 2019, P. 49−54.



Olena Leonidivna Tovazhnyanska, Oksana Ivanivna Kauk, Yevheniia Tarasivna Solovieva, Iryna Oleksandrivna Lapshina, Yuliia Kostiantynivna Remіnyak

Kharkiv National Medical University, Ukraine

Wilson's disease is a rare autosomal recessive inherited disease, the pathogenesis of which is associated with impaired copper metabolism in the body, that leads to its excessive accumulation in various organs and tissues, mainly in the liver and central nervous system. Typically the Wilson's disease manifests mainly at a young age. The history of studying this pathology has been described, wherein the important milestones were mentioned as the determination of the role of impaired copper metabolism in pathogenesis of the disease, the establishment of an autosomal recessive inheritance of Wilson's disease. A mandatory clinical manifestation of Wilson's disease is the formation of neurological symptoms as an akinetic−rigid syndrome, hyperkinesis, ataxia, tremor, muscle dystonia, which is associated with a predominant lesion of basal ganglia, the dentate of the cerebellum and substantia nigra. However, the Wilson's disease can be finally diagnosed only on the basis of a combination of clinical data, the results of an ophthalmic (presence of the Kayser − Fleischer ring) laboratory test and molecular genetic analysis. Treatment for Wilson's disease includes a diet that restricts the intake of foods high in copper, and prolonged use of D−penicillamine (cuprenyl). Zinc preparations and antioxidants are also used. Here we present a clinical case from our own practice of atypically early manifestation of Wilson's disease in a child of the first year of life.

Key words: Wilson’s disease, impaired copper metabolism, early childhood, extrapyramidal disorders, molecular genetic testing.


1. Wilson's disease / A. Ala, A. P. Walker, K. Ashkan [et al.] // Lancet.− 2007.− № 369.− P. 397−408.

2. Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes / P. de Bie, P. Muller, C. Wijmenga, L. W. Klomp // J. Med. Genet.− 2007.− Vol. 44 (11).− P. 673−688.− doi: 10.1136/jmg.2007.052746

3. Roberts E. A. A practice guideline on Wilson disease / E. A. Roberts, M. L. Schilsky // Hepatology.− 2003.− Vol. 37 (6).− P. 1475−1492.− doi: 10.1053/jhep.2003.50252

4. Severe hepatic Wilson's disease in preschool−aged children / D. C. Wilson, M. J. Phillips, D. W. Cox, E. A. Roberts // J. Pediatr.− 2000.− Vol. 137.− P. 719−722.

5. Wilson Disease in Children: Analysis of 57 Cases / N. Manolaki, G. Nikolopoulou, G. L. Daikos [et al.] // J. Pediatr. Gastroenterol Nutr.− 2009.− Vol. 48 (1).− P. 72−77.

6. Beyersdorff A. Morbus Wilson: case report of a two−year−old child as first manifestation / A. Beyersdorff, A. Findeisen // Scand. J. Gastroenterol.− 2006.− Vol. 41.− P. 496−497.

7. Diagnosis of Wilson's disease: an experience over three decades / P. J. Gow, R. A. Smallwood, P. W. Angus [et al.] // Gut.− 2000.− Vol. 46.− P. 415−419.

8. Wilson's disease in adults with cirrhosis but no neurological abnormalities / D. M. Danks, G. Metz, R. Sewell, E. J. Prewett // Br. Med. J.− 1990.− № 301.− R. 331−332.

9. A high index of suspicion: the key to an early diagnosis of Wilson's disease in childhood / I. Sanchez−Albisua, T. Garde, L. Hierro [et al.] // Pediatr. Gastroenterol. Nutr.− 1999.− Vol. 28.− P. 186−190.

10. Schilsky M. L. Diagnosis and treatment of Wilson's disease / M. L. Schilsky // Pediatr. Transpl.− 2002.− Vol. 6.− P. 15−19.

11. Wilson S. A. K. Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver / S. A. K. Wilson // Brain.− 1912.− Vol. 34.− P. 295−507.

12. Fleischer B. Ueber einer der "Pseudosclerose" nahestehende bisher unbekannte Krankheit (gekennzeichnet durch Tremor, psychische Stoerungen, braeunlicke Pigmentierung bestimmter Gewebe, insbesondere Such der Hornhauptperipherie, Lebercirrhose) / B. Fleischer // Deutsch Z Nerven. Heilk.− 1912.− № 44.− R. 179−201.

13. Bickel H. A clinical and biochemical study of hepatolenticular degeneration (Wilson's disease) / H. Bickel, F. C. Neale, G. Hall // Quart. J. Med.− 1957.− № 26.− R. 527−558.

14. Studies on copper metabolism. XVI. Radioactive copper studies in normal subjects and in patients with hepatolenticular degeneration / J. A. Bush, J. P. Mahoney, H. Markowitz [et al.] // J. Clin. Invest.− 1955.− Vol. 34.− P. 1766−1778.

15. Scheinberg I. H. Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's disease) / I. H. Scheinberg, D. Gitlin // Science.− 1952.− Vol. 116.− P. 484−485.

16. Bearn A. G. A genetical analysis of thirty families with Wilson's disease (hepatolenticular degeneration) / A. G. Bearn // Ann. Hum. Genet.− 1960.− Vol. 24.− P. 33−43.

17. Frommer D. J. Defective biliary excretion of copper in Wilson's disease / D. J. Frommer // Gut.− 1974.− Vol. 15, Iss. 2.− P. 125−129.

18. Walshe J. M. Wilson's disease. New oral therapy / J. M. Walshe // Lancet.− 1956.− P. 25−26.

19. Characterization of the Wilson disease gene encoding a P−type copper transporting ATPase: genomic organization, alternative splicing, and structure/function predictions / K. Petrukhin, S. Lutsenko, I. Chernov [et al.] // Hum. Mol. Genet.− 1994.− Vol. 3.− P. 1647−1656.

20. Genotype−phenotype correlation in Italian children with Wilson's disease / E. Nicastro, G. Loudianos, L. Zancan [et al.] // J. Hepatol.− 2009.− Vol. 50.− P. 555−561.

21. Forbes J. R. Copper−dependent trafficking of Wilson disease mutant ATP7B protein / J. R. Forbes, D. W. Cox // Hum. Mol. Genet.− 2000.− Vol. 9.− P. 1927−1935.

22. Ferenci P. Regional distribution of mutations of the ATP7B gene in patients with Wilson disease: impact on genetic testing / P. Ferenci // Hum Genet.− 2006.− Vol. 120.− P. 151−159.

23. Danks D. M. Disorders of copper transport // C. R. Scriver, A. L. Beaudet, W. S. Sly [et al.]. The Metabolic and Molecular Bases of Inherited Disease.− 7th ed.− N. Y.: McGraw−Hill; 1995.− P. 221−235.

24. Tanner S. Disorders of copper metabolism. Diseases of the liver and biliary system in children / S. Tanner, D. A. Kelly // Blackwell Science Ltd.− 2004.− P. 243−258.

25. Vega P. J. Wilson's disease: forms of presentation in childhood / P. J. Vega, L. H. Llanillo // Gastroenterol. Hepatol.− 2006.− Vol. 29 (9).− P. 560−567.

26. Roberts E. A. AASLD Practice Guidelines, Diagnosis and treatment of Wilson disease / E. A. Roberts, M. L. Schilsky // An update.− 2008.− Vol. 47 (6).− P. 2089−2111.

27. MR imaging of the brain in Wilson disease of Childhood: findings before and after treatment with clinical correlation / T. J. Kim, I. O. Kim, W. S. Kim [et al.] // Am. J. Neuroradiol.− 2006.− Vol. 27 (6).− P. 1373−1378.

28. Corpus callosum abnormalities in Wilson's disease / J. M Trocello, J. P. Guichard, A. Leyendecker [et al.] // J. Neurol. Neurosurg Psychiatry.− 2011.− Vol. 82 (10).− P. 1119−1121.− doi: 10.1136/jnnp.2009.204651. Epub 2010 Jul 26

29. Analysis of renal impairment in children with Wilson's disease / X. H. Zhuang, Y. Mo, X. Y. Jiang, S. M. Chen // World. J. Pediatr.− 2008.− Vol. 4 (2).− P. 102−105.

30. Federal'nye klinicheskie rekomendatsii po okazaniyu meditsinskoi pomoshchi detyam s bolezn'yu Vil'sona u detei (Soyuz pediatrov Rossii).− 2013.− 16 s.−

31. Value of urinary copper excretion after penicillamine challenge in the diagnosis of Wilson disease / C. M. Costa, D. Baldwin, B. Portmann [et al.] // Hepatology.− 1992.− Vol. 15.− P. 609−615.

32. Wilson disease: diagnostic dilemmas / R. Iorio, S. Porzio, G. Mazzarella [et al.] // J. Pediatr. Gastroenterol. Nutr.− 2000.− Vol. 31.− P. 93−95.

33. Re−evaluation of the penicillamine challenge test in the diagnosis of Wilson's disease in children / T. Müller, S. Koppikar, R. M. Taylor [et al.] // J. Hepatol.− 2007.− Vol. 47.− P. 270−276.

34. Bioavailability and pharmacokinetics of D−penicillamine / W. R. Kukovetz, E. Beubler, F. Kreuzi [et al.] // J. Rheumatol.− 1983.− Vol. 10.− P. 90−94.

35. Czlonkowska A. Effects of long−term treatment in Wilson's disease with D−penicillamine and zinc sulphate / A. Czlonkowska, J. Gajda, M. Rodo // J. Neurol.− 1996.− Vol. 243.− P. 269−273.

36. Treatment of Wilson's disease with zinc XVI: treatment during the pediatric years / G. J. Brewer, R. D. Dick, V. D. Johnson [et al.] // J. Lab. Clin. Med.− 2001.− Vol. 137.− P. 191−198.

37. Walshe J. M. Zinc−induced deterioration in Wilson's disease aborted by treatment with penicillamine, dimercaprol, and a novel zero copper diet / J. M. Walshe, N. A. Munro // Arch. Neurol.− 1995.− Vol. 52.− P. 10−11.

38. Low vitamin E content in plasma of patients with alcoholic liver disease, hemochromatosis and Wilson's disease / A. von Herbay, H. de Groot, U. Hegi [et al.] // J. Hepatol.− 1994.− Vol. 20.− P. 41−46.

Go on Top